Ionic binding of C3 to the human pathogen Moraxella catarrhalis is a unique mechanism for combating innate immunity
Therése Nordström1, Anna M Blom, Thuan Tong Tan
1Medical Microbiology, Lund University, Malmo University Hospital, Malmo, Sweden.
Abstract:
Moraxella catarrhalis ubiquitous surface proteins A1 and A2 (UspA1/A2) interfere with the classical pathway of the complement system by binding C4b-binding protein. In this study we demonstrate that M. catarrhalis UspA1 and A2 noncovalently and in a dose-dependent manner bind both the third component of complement (C3) from EDTA-treated serum and methylamine-treated C3. In contrast, related Moraxella subspecies (n = 13) or other human pathogenic bacteria (n = 13) do not bind C3 or methylamine-treated C3. Experiments with recombinant proteins and M. catarrhalis mutants devoid of UspA1/A2 revealed that UspA1/A2 exert their actions by absorbing and neutralizing C3 from serum and restrain complement activation. UspA2 was responsible for most of the effect, and the Moraxella mutant lacking UspA2 was more sensitive to the lytic effect of human serum compared with the wild type. Interestingly, among the large number of bacteria analyzed, only M. catarrhalis has this unique ability to interfere with the innate immune system of complement by binding C3.
Insights
Moraxella catarrhalis surface proteins UspA1 and UspA2 uniquely bind and neutralize complement component C3, inhibiting the innate immune system. This mechanism helps the bacteria evade complement-mediated destruction by human serum.
Area of Science:
- Immunology
- Microbiology
- Bacteriology
Background:
- Moraxella catarrhalis is a human pathogen that can cause respiratory infections.
- The complement system is a crucial part of the innate immune system that defends against pathogens.
- Ubiquitous surface proteins A1 and A2 (UspA1/A2) of M. catarrhalis are known to interfere with complement activation.
Purpose of the Study:
- To investigate the interaction between M. catarrhalis UspA1/A2 and the third component of complement (C3).
- To determine if this interaction is unique to M. catarrhalis and its role in immune evasion.
Main Methods:
- Binding assays using recombinant UspA1/A2 proteins and M. catarrhalis mutants.
- Experiments with EDTA-treated and methylamine-treated serum to assess C3 binding.
- Complement activation assays and serum bactericidal assays.
Main Results:
- M. catarrhalis UspA1 and UspA2 bind C3 noncovalently and in a dose-dependent manner.
- This C3 binding neutralizes complement activation, with UspA2 being primarily responsible.
- Other Moraxella subspecies and pathogenic bacteria tested did not exhibit C3 binding.
Conclusions:
- M. catarrhalis possesses a unique mechanism to evade innate immunity by binding and neutralizing C3 via UspA1/A2.
- UspA2 plays a significant role in M. catarrhalis's resistance to complement-mediated lysis.
- This finding highlights a novel immune evasion strategy employed by M. catarrhalis.
Related Concept Videos
Cell-mediated Immune Responses
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Regulation of Bacterial Virulence


